Company Directory / biotechnology

Public · NASDAQ:LPTXFor profitbiotechnologyUnited States
Leap Therapeutics is a clinical-stage biopharmaceutical company for development of targeted and immuno-oncology therapeutics.
Size
11-50 people: larger than 33% of companies with a size listed
Age
15 years old.
Reach
Website ranked #4,835,911 in the world for traffic, about 2k visits a month.
BiotechnologyLife ScienceMedicalOncology
Funding, as listed
$267M currency not stated
What the source datasets report. We have not watched these rounds ourselves.
Everything the source datasets list about Leap Therapeutics, field by field. Contact details are held but never shown.
The company
Where
Size and reach
Funding, as listed
Corporate family
About this record
Growth, as the source summarises it
Leap Therapeutics reported its first quarter 2024 financial results and announced a $40 million private placement.
Summaries written by the source dataset, not by us, and not checked.
biotechnology in United States.
From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 1,637,054 companies in United States and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.